年轻心肌梗死患者可卡因与大麻使用与长期死亡风险
该研究回顾性分析2000至2016年两家学术医院收治的≤50岁首次1型心肌梗死患者共2097例,中位随访11.2年。10.7%患者使用可卡因和/或大麻,校正基线协变量后,其心血管死亡风险(HR 2.22,95%CI 1.27-3.70,P=0.005)和全因死亡风险(HR 1.99,95%CI 1.35-2.97,P=0.001)显著更高。
要点
- ≤50岁心梗患者中10.7%使用可卡因和/或大麻,与长期全因及心血管死亡风险升高独立相关。
- 物质使用者糖尿病和高脂血症比例较低,但吸烟比例显著更高。
- 结果支持对年轻心梗患者进行物质使用筛查并提供咨询。
核心结论
- 在≤50岁1型心肌梗死患者中,可卡因和/或大麻使用与更高的全因死亡和心血管死亡风险独立相关。
研究设计与样本
- 回顾性分析2000至2016年2家学术医院收治的≤50岁1型心肌梗死患者记录,共2097例,中位随访11.2年(四分位距7.3至14.2年)。
主要发现
- 224例(10.7%)使用可卡因和/或大麻,其中可卡因99例(4.7%),大麻125例(6.0%)。
- 物质使用组糖尿病比例14.7%对20.4%(p=0.05),高脂血症比例45.7%对60.8%(p<0.001),吸烟比例70.3%对49.1%(p<0.001)。
- 校正基线协变量后,可卡因和/或大麻使用与心血管死亡风险升高相关(HR 2.22,95%CI 1.27-3.70,p=0.005)。
- 校正基线协变量后,可卡因和/或大麻使用与全因死亡风险升高相关(HR 1.99,95%CI 1.35-2.97,p=0.001)。
临床怎么用
- 对年轻心肌梗死患者应筛查可卡因和大麻使用,并提供咨询以预防未来不良事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Substance abuse is increasingly prevalent among young adults, but data on cardiovascular outcomes remain limited. OBJECTIVES: The objectives of this study were to assess the prevalence of cocaine and marijuana use in adults with their first myocardial infarction (MI) at ≤50 years and to determine its association with long-term outcomes. METHODS: The study retrospectively analyzed records of patients presenting with a type 1 MI at ≤50 years at 2 academic hospitals from 2000 to 2016. Substance abuse was determined by review of records for either patient-reported substance abuse during the week before MI or substance detection on toxicology screen. Vital status was identified by the Social Security Administration's Death Master File. Cause of death was adjudicated using electronic health records and death certificates. Cox modeling was performed for survival free from all-cause and cardiovascular death. RESULTS: A total of 2,097 patients had type 1 MI (mean age 44.0 ± 5.1 years, 19.3% female, 73% white), with median follow-up of 11.2 years (interquartile range: 7.3 to 14.2 years). Use of cocaine and/or marijuana was present in 224 (10.7%) patients; cocaine in 99 (4.7%) patients, and marijuana in 125 (6.0%). Individuals with substance use had significantly lower rates of diabetes (14.7% vs. 20.4%; p = 0.05) and hyperlipidemia (45.7% vs. 60.8%; p < 0.001), but they were significantly more likely to use tobacco (70.3% vs. 49.1%; p < 0.001). The use of cocaine and/or marijuana was associated with significantly higher cardiovascular mortality (hazard ratio: 2.22; 95% confidence interval: 1.27 to 3.70; p = 0.005) and all-cause mortality (hazard ratio: 1.99; 95% confidence interval: 1.35 to 2.97; p = 0.001) after adjusting for baseline covariates. CONCLUSIONS: Cocaine and/or marijuana use is present in 10% of patients with an MI at age ≤50 years and is associated with worse all-cause and cardiovascular mortality. These findings reinforce current recommendations for substance use screening among young adults with an MI, and they highlight the need for counseling to prevent future adverse events.
引用
- DeFilippis EM, Singh A, Divakaran S, et al. Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2018. PMID: 29535062. doi:10.1016/j.jacc.2018.02.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。